AU501685B2 - D-homo-20-keto pregnanes - Google Patents

D-homo-20-keto pregnanes

Info

Publication number
AU501685B2
AU501685B2 AU87637/75A AU8763775A AU501685B2 AU 501685 B2 AU501685 B2 AU 501685B2 AU 87637/75 A AU87637/75 A AU 87637/75A AU 8763775 A AU8763775 A AU 8763775A AU 501685 B2 AU501685 B2 AU 501685B2
Authority
AU
Australia
Prior art keywords
homo
pregnanes
keto
keto pregnanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU87637/75A
Other languages
English (en)
Other versions
AU8763775A (en
Inventor
U. Wiechert R. Wachtel H. Engelfried Kieslich K Herb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742461312 external-priority patent/DE2461312A1/de
Priority claimed from DE19752506688 external-priority patent/DE2506688A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of AU8763775A publication Critical patent/AU8763775A/en
Application granted granted Critical
Publication of AU501685B2 publication Critical patent/AU501685B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU87637/75A 1974-12-23 1975-12-17 D-homo-20-keto pregnanes Expired AU501685B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEDE2461312 1974-12-23
DE19742461312 DE2461312A1 (de) 1974-12-23 1974-12-23 D-homo-20-keto-pregnane und verfahren zu ihrer herstellung
DEDE2506688 1975-02-14
DE19752506688 DE2506688A1 (de) 1975-02-14 1975-02-14 D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
AU8763775A AU8763775A (en) 1977-06-23
AU501685B2 true AU501685B2 (en) 1979-06-28

Family

ID=25768157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87637/75A Expired AU501685B2 (en) 1974-12-23 1975-12-17 D-homo-20-keto pregnanes

Country Status (13)

Country Link
US (1) US4056633A (enExample)
JP (1) JPS5188953A (enExample)
AU (1) AU501685B2 (enExample)
CA (1) CA1051868A (enExample)
DD (1) DD123329A5 (enExample)
DK (1) DK138501C (enExample)
ES (1) ES443825A1 (enExample)
FR (1) FR2295739A1 (enExample)
GB (1) GB1538869A (enExample)
IL (1) IL48628A0 (enExample)
LU (1) LU74087A1 (enExample)
NL (1) NL7514976A (enExample)
SE (1) SE7514514L (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104306A (en) * 1976-05-05 1978-08-01 Abbott Laboratories 12A-Deoxy chelocardin
US5439900A (en) * 1993-02-25 1995-08-08 Bukusoglu; Cuneyt Methods and compositions for providing analgesia and enhanced anesthesia
CA2495412A1 (en) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169832A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
HRP20210610T1 (hr) 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3885352B1 (en) 2014-10-16 2024-11-27 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
EP4275748A3 (en) 2014-10-16 2024-01-03 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
AU2018392093B2 (en) * 2017-12-22 2024-02-01 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
US11718642B2 (en) * 2018-01-12 2023-08-08 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
TW202521129A (zh) 2018-12-05 2025-06-01 美商賽吉醫療公司 神經活性類固醇及其使用方法
KR102821994B1 (ko) * 2019-01-08 2025-06-19 쳉두 캉홍 파마슈티칼 코., 엘티디. 스테로이드 화합물, 및 이의 용도와 제조방법
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc
CN114787174A (zh) * 2019-06-27 2022-07-22 萨奇治疗股份有限公司 用于治疗cns病症的组合物和方法
CA3143545A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876705A (en) * 1972-06-12 1975-04-08 Univ New Brunswick Steroid total synthesis and intermediates

Also Published As

Publication number Publication date
DK588775A (da) 1976-06-24
CA1051868A (en) 1979-04-03
SE7514514L (sv) 1976-06-24
IL48628A0 (en) 1976-02-29
GB1538869A (en) 1979-01-24
NL7514976A (nl) 1976-06-25
DK138501B (da) 1978-09-18
DD123329A5 (enExample) 1976-12-12
AU8763775A (en) 1977-06-23
FR2295739A1 (fr) 1976-07-23
LU74087A1 (enExample) 1976-07-20
DK138501C (da) 1979-02-19
JPS5188953A (en) 1976-08-04
ES443825A1 (es) 1977-05-01
US4056633A (en) 1977-11-01

Similar Documents

Publication Publication Date Title
AU498050B2 (en) Pallet-container
AU501685B2 (en) D-homo-20-keto pregnanes
AU497500B2 (en) Adriamycins
AU497203B2 (en) Neohelometer
AU500773B2 (en) Carbonylaldiminomethanephosphonates
AU497283B2 (en) 1-thiadiazolimidazolidinones
AU499460B2 (en) Antiobotics
AU467292B2 (en) Eye-bush
AU496973B2 (en) 5-nitro-imidazoles
AU499459B2 (en) Antioboitics
AU503202B2 (en) 3-methylenecepham sulfonides
AU499812B2 (en) Halo-pregnanes
AU497650B2 (en) 2-aryl-4-cyanomethyl-5-methylimidazoles
AU492680B2 (en) Novel steroids
AU491546B2 (en) Novel steroids
AU487545B2 (en) Handstamp
AU485931B2 (en) Triazine-diones
AU484632B2 (en) Aryloxyphenylpropylamines
AU484806B2 (en) Benzopyran-3-carbonitriles
AU485075B2 (en) 2-nitroimidazoles
AU486206B2 (en) Triazolobenzodiazepines
AU486856B2 (en) Indolobenzazepines
AU482524B2 (en) Pyridoindoles
AU487605B2 (en) Bulbholder
AU491257B2 (en) 11b-fluoro-androstenes